Rare Tumors Archives

FDA Approves Bone-Softening Disorder Treatment Crysvita

Approvals, FDA/Regulatory, Priority Review, Rare Diseases, Rare Tumors, Tumor-Induced Osteomalacia (TIO)

The U.S. Food and Drug Administration approved Crysvita (burosumab) for the treatment of a rare disease, tumor-induced osteomalacia.

June 19, 2020/by BioSpace

FDA approves first treatment for rare adrenal tumors

Accelerated Review, Adrenal Tumors, Approvals, Breakthrough Therapy Designation, Fast Track Designation, FDA, FDA/Regulatory, First-of-its kind, Pheochromocytomas, Priority Review, Rare Tumors

The FDA approved Azedra injection for intravenous use for treating patients age 12 and older with rare tumors of the adrenal gland that cannot be surgically removed, have spread beyond the original tumor site and require systemic anticancer therapy.

July 30, 2018/by PR Newswire